 |
|
The Development of Evidence-Based Guideline for Diagnosis and Management of Headache in Korea
Sun Mi Kim, Young-Hoon Ko, Seoyoung Yoon, Won Sub Kang, Hye-Geum Kim, Hye Youn Park, Cheolmin Shin, Yoo Hyun Um, Soyoung Youn, Jae-Hon Lee, Seung-Ho Jang, Sang Won Jeon, Hong Jun Jeon, Seockhoon Chung, Jae-Won Choi, Kyu-Man Han, Sang-Yeol Lee
Psychiatry Investig. 2019;16(3):199-205. Published online 2019 Mar 21 DOI: https://doi.org/10.30773/pi.2018.11.23
|
|
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Shengyuan Yu, Byung-Kun Kim, Aihong Guo, Man-Ho Kim, Mingjie Zhang, Zhen Wang, Jianguang Liu, Heui-Soo Moon, Ge Tan, Qian Yang, Donnie McGrath, Michael Hanna, David A Stock, Yanfei Gao, Robert Croop, Zhihong Lu
The Lancet Neurology.2023; 22(6): 476. CrossRef Identifying Outcome Measures for Migraine Value‐Based Contracting Using the Delphi Method
Elizabeth C. S. Swart, Chester B. Good, Rochelle Henderson, Chronis Manolis, Claire Yanta, Natasha Parekh, Lynn M. Neilson
Headache: The Journal of Head and Face Pain.2020; 60(10): 2139. CrossRef Meta-analysis on the Efficacy of Glutamate Receptor Antagonists for Acute Migraine Treatment
Sunhee Kim, In-hwan Baek
Korean Journal of Clinical Pharmacy.2019; 29(4): 247. CrossRef
|